23andMe is using its customers’ genetic data to try to become a new kind of pharma company. By Kristen V. Brown

How a Die-Hard Libertarian Is Negotiating Lower Health-Care Costs
22:36

James Patterson’s Authorship Operation Welcomes Viola Davis and MrBeast
38:15

The Caribbean Nation Unexpectedly Going Along With Trump’s Drug-Boat Narrative
13:32